PANCREATIC CANCER NON-RESECTABLE
Clinical trials for PANCREATIC CANCER NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER NON-RESECTABLE trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of drugs aims to tackle tough pancreatic cancer
Disease control Not yet recruitingThis study tests a combination of four drugs—tunlametinib, two chemotherapies, and a targeted antibody—as a first treatment for people with advanced pancreatic cancer that cannot be removed by surgery. The trial will enroll 28 patients who have not had prior therapy. Researchers …
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: PHASE4 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
AI trained on thousands of pancreatic cancer cases could revolutionize diagnosis
Knowledge-focused Not yet recruitingThis study collects and organizes data from 3,000 real pancreatic cancer patients, including those with early, advanced, and inoperable disease. Medical experts will label and structure the information to create a high-quality knowledge base. The goal is to train artificial intel…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC